Key | % Net Assets |
---|---|
BP | 5.0% |
HSBC | 4.9% |
GlaxoSmithKline | 4.5% |
Vodafone | 3.3% |
Other | 82.3% |
Name | % Net Assets |
---|---|
BP | 5.0% |
HSBC | 4.9% |
GlaxoSmithKline | 4.5% |
Vodafone | 3.3% |
Royal Dutch Shell 'B' | 3.2% |
Legal & General Group | 3.1% |
Rio Tinto | 3.1% |
BT | 2.9% |
Reed Elsevier | 2.8% |
Centrica | 2.5% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 679.59p |
Currency | GBP |
Change | 4.88p |
% | 0.72% |
YTD change | 74.16p |
YTD % | 12.25% |
Fund Inception | 06/06/2000 |
---|---|
Fund Manager | Adrian Frost / Adrian Gosden |
TER | 0.80 (31-May-2012) |
Minimum Investment | |
---|---|
Initial | £250000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 1.00% |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research